Cite
VDAC1 as a target in cisplatin anti-tumor activity through promoting mitochondria fusion.
MLA
Luo, Lei, et al. “VDAC1 as a Target in Cisplatin Anti-Tumor Activity through Promoting Mitochondria Fusion.” Biochemical & Biophysical Research Communications, vol. 560, June 2021, pp. 52–58. EBSCOhost, https://doi.org/10.1016/j.bbrc.2021.04.104.
APA
Luo, L., Xiong, Y., Jiang, N., Zhu, X., Wang, Y., Lv, Y., & Xie, Y. (2021). VDAC1 as a target in cisplatin anti-tumor activity through promoting mitochondria fusion. Biochemical & Biophysical Research Communications, 560, 52–58. https://doi.org/10.1016/j.bbrc.2021.04.104
Chicago
Luo, Lei, Yanyan Xiong, Nan Jiang, Xueqin Zhu, Yurun Wang, Yuan Lv, and Ying Xie. 2021. “VDAC1 as a Target in Cisplatin Anti-Tumor Activity through Promoting Mitochondria Fusion.” Biochemical & Biophysical Research Communications 560 (June): 52–58. doi:10.1016/j.bbrc.2021.04.104.